TMCI catalyst calendar

TREACE MEDICAL CONCEPTS, INC.

Upcoming catalysts
1
Cash runway
Cash generating
Cash & investments
$46M
Phase 3 programs
1

TREACE MEDICAL CONCEPTS, INC. is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Surgical & Medical Instruments & Apparatus.

The next scheduled catalyst is A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries. on December 15, 2027. There is 1 upcoming event on record.

TREACE MEDICAL CONCEPTS, INC. generates cash from operations, so a burn-based runway figure does not apply.

Upcoming catalysts

DateEventTypePhase
December 15, 2027 A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries. Trial Milestone Phase 2/Phase 3

Track TMCI alongside other companies. Add it to a watchlist and see every catalyst on one calendar.

Open TMCI in the tracker

Recent history

DateEventTypePhase
August 7, 2026 Quarterly results filed (8-K) Earnings —
May 8, 2026 Quarterly results filed (8-K) Earnings —
April 9, 2026 Quarterly results filed (8-K) Earnings —
February 27, 2026 Quarterly results filed (8-K) Earnings —
January 13, 2026 Quarterly results filed (8-K) Earnings —
December 18, 2025 8-K filed: Material agreement, Reg FD disclosure, Other event Corporate —
November 6, 2025 Quarterly results filed (8-K) Earnings —
August 7, 2025 Quarterly results filed (8-K) Earnings —
May 8, 2025 Quarterly results filed (8-K) Earnings —

About this data

Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.

Last updated 2026-10-14.